Skip to main content
DNA Labs India

Liquid Bx. Cell Free PAN RAS (KRAS,NRAS) Test

DNA Labs India | ISO 9001:2015 Certified

Liquid Bx. Cell Free PAN RAS (KRAS,NRAS) Test

Short Name: Liquid PAN RAS

Also known as: Cell-Free PAN RAS Mutation Panel, Liquid Biopsy KRAS NRAS, ctDNA RAS Panel

Liquid Bx. Cell Free PAN RAS (KRAS,NRAS) Test test available at DNA Labs India for ₹27,000. Uses Droplet Digital PCR on Peripheral Blood samples. Results in Reports are available within 5-7 days after sample collection.. Free home collection in 300+ cities across India.

Liquid Biopsy🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the Liquid Bx. Cell Free PAN RAS (KRAS,NRAS) test is to identify mutations in the KRAS and NRAS genes from circulating tumor DNA (ctDNA). This helps in: 1) Early detection of cancer, 2) Guiding targeted therapy decisions, 3) Monitoring treatment response, 4) Detecting minimal residual disease, 5) Identifying acquired resistance to anti-EGFR therapy. The test is non-invasive, reducing the need for tissue biopsies, and provides real-time molecular information.

Test Code
6116
CPT Code
81479
ICD Code
Z12.9
Price
₹27,000
Sample Type
Peripheral Blood
Result Time
Reports are available within 5-7 days after sample collection.
Fasting Required
No
Method
Droplet Digital PCR
Step 1

Sample Collection

No special preparation is required. However, a doctor's prescription is mandatory. Inform your doctor about any medications you are taking.

Method: Venipuncture

Step 2

Laboratory Analysis

A blood sample will be drawn from a vein in your arm. The procedure is quick and minimally invasive.

Step 3

Report Delivery

You can resume normal activities immediately. No restrictions are required.

Timeline: Reports are available within 5-7 days after sample collection.

Patient Instructions

1
Before the Test:No special preparation. Ensure you have a doctor's prescription.
2
During the Test:Blood sample collection takes about 5 minutes.
3
After the Test:No restrictions. You can resume normal activities.

About This Test

Who Should Get This Test

The purpose of the Liquid Bx. Cell Free PAN RAS (KRAS,NRAS) test is to identify mutations in the KRAS and NRAS genes from circulating tumor DNA (ctDNA). This helps in: 1) Early detection of cancer, 2) Guiding targeted therapy decisions, 3) Monitoring treatment response, 4) Detecting minimal residual disease, 5) Identifying acquired resistance to anti-EGFR therapy. The test is non-invasive, reducing the need for tissue biopsies, and provides real-time molecular information.

How to Prepare

  • Use Streck tube for collection
  • Fill tube to the indicated mark
  • Mix gently by inverting 8-10 times
  • Do not refrigerate or freeze
  • Transport at ambient temperature (15-25°C)
  • Ensure sample reaches lab within 72 hours

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"Liquid biopsy for RAS mutations is a breakthrough in personalized oncology, enabling non-invasive monitoring and early detection of resistance."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypePeripheral Blood
Sample Volume10 mL
ContainerStreck Tube
Collection MethodVenipuncture

Sample Stability

Ambient (15-25°C)72 hours
Refrigerated (2-8°C)Not recommended
Frozen (-20°C)Not recommended
Sample Rejection Criteria:
  • Clotted sample
  • Hemolyzed sample
  • Incorrect tube used
  • Sample older than 72 hours
  • Insufficient volume

Understanding Your Results

The test detects the presence or absence of KRAS and NRAS mutations. A 'Not Detected' result indicates no mutation was found in the tested hotspots. A 'Detected' result indicates the presence of a mutation, which may guide targeted therapy.
📊

KRAS/NRAS mutation detected

Presence of RAS mutation; may predict resistance to anti-EGFR therapy (e.g., cetuximab, panitumumab) in colorectal cancer.

Action: Discuss alternative targeted therapies or chemotherapy options with oncologist.

📊

KRAS/NRAS mutation not detected

No mutation found in tested hotspots; patient may be eligible for anti-EGFR therapy.

Action: Consider anti-EGFR therapy if clinically indicated.

📊

Inconclusive

Insufficient ctDNA or technical issue; repeat test or consider tissue biopsy.

Action: Repeat test after 2-4 weeks or proceed with tissue biopsy.

⚠️ When to Consult a Doctor:

Consult your oncologist if you have symptoms like unexplained weight loss, persistent fatigue, blood in stool or urine, persistent pain, or lumps. Also, if you have a family history of cancer, discuss screening options.

Limitations

  • May not detect mutations if ctDNA is below detection limit
  • Not a standalone diagnostic test for cancer
  • Results should be correlated with clinical and radiological findings
  • Cannot detect all RAS mutations (only common hotspots)
  • Not recommended for hematological malignancies

Risks & Considerations

  • Minimal risk of bruising at puncture site
  • Rare risk of infection
  • Fainting or dizziness during blood draw

Interfering Factors

  • Hemolysis of blood sample
  • Insufficient blood volume
  • Sample not collected in Streck tube
  • Delay in processing beyond 72 hours
  • High background cfDNA from non-tumor sources

Compare With Similar Tests

TestLiquid Bx. Cell Free PAN RAS (KRAS,NRAS)Tissue Biopsy RAS TestingLiquid Biopsy (this test)
ComparisonLiquid Bx. Cell Free PAN RAS (KRAS,NRAS)

Frequently Asked Questions

What is the cost of the Liquid Bx. Cell Free PAN RAS (KRAS,NRAS) test?
The cost is INR 27,000 at DNA Labs India, with free home sample collection.
What is the sample type required?
Peripheral blood sample collected in a Streck tube.
Is fasting required before the test?
No, fasting is not required.
How long does it take to get results?
Reports are available within 5-7 days.
Is a doctor's prescription necessary?
Yes, a doctor's prescription is required, except for surgery, pregnancy, or travel-related cases.
What mutations does this test detect?
It detects common hotspot mutations in KRAS and NRAS genes (codons 12, 13, 61, 117, 146).
Is this test covered by insurance?
Coverage varies by insurance provider; please check with your insurer.
Can this test detect cancer before symptoms appear?
Yes, it can detect circulating tumor DNA, potentially before symptoms manifest.
What is the difference between liquid biopsy and tissue biopsy?
Liquid biopsy is non-invasive and captures tumor heterogeneity, while tissue biopsy is invasive but provides direct tumor tissue analysis.
Are there any risks associated with the test?
Risks are minimal, similar to routine blood draw, including bruising or infection at the puncture site.
Can this test be done at home?
Yes, DNA Labs India offers free home sample collection for this test.
What should I do if my result is positive for a mutation?
Consult your oncologist to discuss targeted therapy options and further management.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.